Genetic Testing

In 2015, ASHG issued a position statement on ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Published in The American Journal of Human Genetics, the statement aims to guide approaches to genetic testing for children in the research and clinical contexts. Related: Infographics: Pediatric Genetic Testing (March 2016) Points to Consider:... Read More

Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org For Immediate Release Thursday, July 2, 2015 12:00 pm U.S. Eastern Time (UTC-05:00) Statement Addresses Scientific Advances, Ethical Questions, and Implementation BETHESDA, MD – The American Society of Human Genetics (ASHG) Workgroup on Pediatric Genetic and Genomic Testing has issued a position statement on Points to... Read More

Following rapid innovation in non-invasive prenatal testing (NIPT), ASHG and the European Society of Human Genetics published a joint statement in the European Journal of Human Genetics that addressed the responsible use of these tests across conditions and how they might fit with existing approaches. Related: Statement: Non-invasive Prenatal Testing for Aneuploidy and Beyond: Challenges... Read More

In 2015, the U.S. Food and Drug Administration (FDA) invited comment on its draft guidance for the regulatory oversight of laboratory-developed tests (LDTs). With a focus on genetic and genomic testing, ASHG submitted comments on the proposed regulatory oversight of such tests. Related: Comments Submitted in Response to FDA’s Draft Guidance: Framework for Regulatory Oversight... Read More

NEWS For more information: Cathy Yarbrough press@ashg.org sciencematter@yahoo.com 858-243-1814 Embargo: 8 a.m. ET, Thursday, Oct. 24, 2013 Since 1994, many thousands of women with breast cancer from families severely affected with the disease have been tested for inherited mutations in BRCA1 and BRCA2. The vast majority of those patients were told that their gene sequences... Read More